Clinical Trials Directory

Trials / Completed

CompletedNCT00424450

Assessment of Bypass Surgery and Balloon Angioplasty Effects in Peripheral Arterial Disease Using Contrast Ultrasound

Assessment of Revascularization Effects in Peripheral Arterial Disease Using Contrast Ultrasound Tissue Perfusion Imaging (REVASC-PI)

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University Hospital Freiburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Contrast ultrasound perfusion imaging (CUPI) is a novel tool for the assessment of muscle perfusion deficits in peripheral arterial disease (PAD). In this study we want to examine the effect of bypass surgery and balloon angioplasty on the calf muscle blood supply. We hope find a new way of quantifying success or failure of invasive treatment strategies.

Detailed description

Contrast ultrasound perfusion imaging (CUPI) was developed at the University Hospital of Freiburg, Germany in 2005 for the assessment of skeletal muscle perfusion deficits in peripheral arterial disease (PAD). It has been reported previously by the investigators that the contrast agent wash-in is significantly prolonged in PAD with respect to the extent of disease and with respect to the degree of collateralization. The goal of this study is to examine the effect of revascularization procedures on muscular perfusion in 15 PAD patients undergoing lower limb artery bypass surgery and 15 PAD patients undergoing percutaneous angioplasty (PTA) before and after intervention. Based on the data from a pilot study, a power calculation for an alpha = 5% with a power of 80% and an assumed standard deviation of 10 s yielded a necessary patient number of 29 per group to detect a decrease in wash-in time of 7.5 s. In this intra-individual comparison we aim to compare 30 patients pre with the same 30 patients post revascularization. We hypothesize 1) that the contrast agent wash-in in the target muscle will significantly improve after revascularization and 2) that standard non-invasive tests such ankle-brachial index (ABI) will not correlate with the CUPI findings. The results of this trial will help to further understand the diagnostic accuracy of CUPI in quantifying limb muscle perfusion deficits. Patients with symptomatic PAD and an indication for revascularization will undergo CUPI less than 8 weeks prior and less than 3 weeks after the revascularization procedure. A second follow-up CUPI examination is performed 3 - 6 months after the revascularization procedure.

Conditions

Interventions

TypeNameDescription
PROCEDURElower limb artery bypass surgerybypass of severe atherosclerotic vascular lesion
PROCEDUREpercutaneous angioplasty (PTA)PTA of severe atherosclerotic lesion

Timeline

Start date
2006-10-01
Primary completion
2009-01-01
Completion
2009-07-01
First posted
2007-01-19
Last updated
2018-10-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00424450. Inclusion in this directory is not an endorsement.